We are live on ! Find out more
ENVB icon

Enveric Biosciences
ENVB

14 hedge funds and large institutions have $387K invested in Enveric Biosciences in 2024 Q4 according to their latest regulatory filings, with 2 funds opening new positions, 5 increasing their positions, 3 reducing their positions, and 1 closing their positions.

New
Increased
Maintained
Reduced
Closed

100% more first-time investments, than exits

New positions opened: 2 | Existing positions closed: 1

67% more repeat investments, than reductions

Existing positions increased: 5 | Existing positions reduced: 3

15% more capital invested

Capital invested by funds: $337K → $387K (+$49.5K)

8% more funds holding

Funds holding: 13 → 14 (+1)

0.01% more ownership

Funds ownership: 0.04% → 0.06% (+0.01%)

Holders
14
Holders Change
+1
Holders Change %
+7.69%
% of All Funds
0.18%
Holding in Top 10
–
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
–
New
2
Increased
5
Reduced
3
Closed
1
Calls
–
Puts
–
Net Calls
–
Net Calls Change
–

Top Buyers

Rank Fund Capital Flow
1
AI
AdvisorShares Investments
Maryland
+$93.9K
2
UBS Group
UBS Group
Switzerland
+$31.3K
3
VF
Virtu Financial
New York
+$13.2K
4
XT
XTX Topco
Cayman Islands
+$8.85K
5
Jane Street
Jane Street
New York
+$4.35K

Top Sellers

Rank Fund Capital Flow
1
TRCT
Tower Research Capital (TRC)
New York
-$3.48K
2
Geode Capital Management
Geode Capital Management
Massachusetts
-$581
3
Two Sigma Investments
Two Sigma Investments
New York
-$508
4
Osaic Holdings
Osaic Holdings
Arizona
-$271
Name Holding Trade Value Shares
Change 		Change in
Stake
AI
1
AdvisorShares Investments
Maryland
$215K +$93.9K +1,294 +63%
Geode Capital Management
2
Geode Capital Management
Massachusetts
$77.6K -$581 -8 -0.7%
UBS Group
3
UBS Group
Switzerland
$28.1K +$31.3K +432 +10,800%
VF
4
Virtu Financial
New York
$20K +$13.2K +182 +142%
TSS
5
Two Sigma Securities
New York
$11.4K +$508 +7 +4%
XT
6
XTX Topco
Cayman Islands
$7.89K +$8.85K +122 New
Vanguard Group
7
Vanguard Group
Pennsylvania
$6.51K – – –
Citadel Advisors
8
Citadel Advisors
Florida
$5.38K +$871 +12 +17%
Two Sigma Investments
9
Two Sigma Investments
New York
$4.35K -$508 -7 -9%
Jane Street
10
Jane Street
New York
$3.88K +$4.35K +60 New
BlackRock
11
BlackRock
New York
$3.23K – – –
TRCT
12
Tower Research Capital (TRC)
New York
$3.15K -$3.48K -48 -49%
Group One Trading
13
Group One Trading
Illinois
$98 – – –
Bank of America
14
Bank of America
North Carolina
$65 – – –
National Bank of Canada
15
National Bank of Canada
Quebec, Canada
$25 – – –
AWM
16
Avior Wealth Management
Nebraska
$17 – – –
SS
17
SBI Securities
Japan
$7 – – –
Wells Fargo
18
Wells Fargo
California
$6 – – –
Osaic Holdings
19
Osaic Holdings
Arizona
– -$271 -3 Closed

ENVB Hedge Fund Activity: Q4 2024 in Review

14 of the 7,597 institutional investors tracked by Wall St. Rank reported a position in Enveric Biosciences (ENVB) for Q4 2024, worth a combined $387K — up 15% from $337K a quarter earlier.

Buyers outnumbered sellers: 2 funds opened new ENVB positions and 1 closed out — a net gain of 1 holder — while 5 added to existing stakes and 3 trimmed.

The largest buyer was AdvisorShares Investments, adding an estimated $93.9K. The largest seller was Tower Research Capital (TRC), cutting an estimated $3.48K.

  • 14 institutional investors held Enveric Biosciences (ENVB) as of Q4 2024, up from 13 in Q3 2024.
  • Funds reported $387K of Enveric Biosciences stock for Q4 2024, up 15% quarter-over-quarter.
  • 2 funds opened new Enveric Biosciences positions in Q4 2024 and 1 closed out, a net change of +1 holder.
  • The largest Enveric Biosciences buyer in Q4 2024 was AdvisorShares Investments, an estimated $93.9K added.
  • The largest Enveric Biosciences seller in Q4 2024 was Tower Research Capital (TRC), an estimated $3.48K sold.

Based on aggregated 13F filings for Q4 2024.